medline.ch Onkologie Urologische Tumoren

	Gold Nanoparticles in Bladder Cancer Applications: A Paradigm Shift from Diagnostic Tools to Integrated Theranostic Platforms. Int J Nanomedicine Zhang X, Wu X, Du J, Mei J, Chen F, Lou K. PMID: 41869400 [PubMed - as supplied by publisher]
	Cause-specific mortality beyond prostate cancer in young men: a population-based study of second malignancies and non-tumor causes. Am J Transl Res Kang Y, Liu J, Lin Y, Pang L. PMID: 41868909 [PubMed - as supplied by publisher]
	Identification of risk factors for the development and prognosis of bone metastases in renal cell carcinoma: development and validation of a predictive model. Am J Cancer Res Zeng W, Wu Z, Sun Y, Ma M, Fan A, Liu Z, Luo S. PMID: 41868662 [PubMed - as supplied by publisher]
	Phellinus linteus polysaccharides inhibit castration-resistant prostate cancer progression possibly via dual modulation of PIK3R1 and PGC-1Î±: a preclinical evaluation. Am J Cancer Res Wei W, Huang J, Xie L, Xu Z, Lin C, Chen M. PMID: 41868659 [PubMed - as supplied by publisher]
	Diagnostic Value of Multiparametric Transrectal Ultrasound in Patients with Suspected Carcinoma of Prostate: A Tertiary Care Centre Experience. Indian J Radiol Imaging Chowhan PS, Gorsi U, Mavuduru R, Lal A, Mete UK, Kakkar N. PMID: 41867289 [PubMed]
	Diagnosis of penile cancer with ex vivo fluorescence confocal microscopy using the HistologÂ® Scanner. BJU Int Zhang X, Almeida-Magana R, Mendes LST, Lavergne DF, Alnajjar H, Shaw G, Freeman A, Muneer A, Haider A. PMID: 41867020 [PubMed - as supplied by publisher]
	NICE 2026 guideline for the diagnosis and management of kidney cancer. Lancet Oncol Stewart GD, Boyce S, Harrisingh MC, Crane O, NICE Kidney Cancer Guideline Committee Members. PMID: 41865753 [PubMed - as supplied by publisher]
	DaBlaCa-13 Study: Five-year Follow-up from the Randomized Controlled Trial of Chemoresection with Intravesical Mitomycin C in Recurrent Ta Non-muscle-invasive Bladder Cancer. Eur Urol Oncol Klingenberg S, Lindgren MS, Jakobsen JK, Jensen JB, Kingo PS. PMID: 41864769 [PubMed - as supplied by publisher]
	Re: Hiroshi Kitamura, Taiji Tsukamoto, Yoshiyuki Kakehi, et al. Active Surveillance Versus Intravesical Bacillus Calmette-GuÃ©rin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.01.008. Eur Urol Contieri R, Lazzeri M, Perdonà S, Hurle R. PMID: 41864760 [PubMed - as supplied by publisher]
	Reply to Roberto Contieri, Massimo Lazzeri, Sisto PerdonÃ , and Rodolfo Hurle's Letter to the Editor re: Kitamura, Tsukamoto T, Kakehi Y, et al. Active Surveillance Versus Intravesical Bacillus Calmette-GuÃ©rin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.008. Eur Urol Kitamura H, Nishiyama H. PMID: 41864759 [PubMed - as supplied by publisher]
	Pushing the boundaries of SBRT in irradiated territories for nodal oligorecurrent prostate cancer: outcomes of the CYGNUS multicentric retrospective study. Int J Radiat Oncol Biol Phys Anger E, Supiot S, Josset Q, Pasquier D, Vaugier L, Riet FG, Pointreau Y, Ruffier A, Loos G, Terlizzi M, Blanchard P, Martin E, Sargos P, Guerni M, Schick U, Bera G, Roman J, Latorzeff I, Créhange G, Castelli J, Barateau A, De Crevoisier R, Nicosia L, Guévelou JL. PMID: 41864432 [PubMed - as supplied by publisher]
	Reduced Prostate Cancer Risk in Patients with Androgenetic Alopecia Using 5-Alpha Reductase Inhibitors: A TriNetX Real-World Cohort Study. J Am Acad Dermatol Chen YJ, Liu WT, Yang CC. PMID: 41864295 [PubMed - as supplied by publisher]
	Endothelial SMAD1-MCAM axis facilitates sunitinib resistance and progression of clear cell renal cell carcinoma via LAMB1-ITGB1 signaling. Drug Resist Updat Zhang H, Liu Y, Zhang W, Guo Y, Lin A, Jin Y, Lu P, Fang Y, Zhang H, Qu L, Luo P, Wu L, Chen Y, Kang X, Wang L, Jiang A. PMID: 41864072 [PubMed - as supplied by publisher]
	Hematuria-related readmission after transurethral resection of bladder tumor in patients receiving antiplatelet therapy. Urologia Ilktac A, Dogan B, Gevher F, Akcay M, Akbulut H, Ilbey YO. PMID: 41863856 [PubMed - as supplied by publisher]
	Surgical Management of Bone Metastases in Bladder Cancer: A Single-Center Retrospective Study. Cancer Rep (Hoboken) Doumanidis P, Tsagkozis P. PMID: 41863065 [PubMed - indexed for MEDLINE]
	PARTIAL: study protocol for a clinical and cost-effectiveness of complex PARTIAL vs radical nephrectomy for clinically localised renal cell carcinoma randomised trial. Trials Johnson D, Thomas R, Cotton S, Newlands R, Cooper D, McCann S, Vale L, Gillies K, Bex A, Challacombe B, Falloon J, MacLennan G, Narahari K, Nicol D, Sheerin N, Stewart GD, Tran M, Heer R, Soomro N. PMID: 41863008 [PubMed - as supplied by publisher]
	Association between presurgical physical activity and urinary and sexual function in prostate cancer patients treated by radical prostatectomy: A prospective cohort study. Urol Oncol Harper A, Khan M, Imm KR, Grubb RL 3rd, Kim EH, Colditz GA, Wolin KY, Kibel AS, Sutcliffe S, Yang L. PMID: 41862406 [PubMed - as supplied by publisher]
	Blood and Urine Circulating Tumor DNA in Urothelial Bladder Cancer: State of the Art and Clinical Perspective. Eur Urol Oncol Duquesne I, Epelbaum I, Prost D, Haberstich M, Suartz CV, Blons H, Taly V, Laurent-Puig P, Horowitz A, Sfakianos JP, Thibault C, Audenet F. PMID: 41862336 [PubMed - as supplied by publisher]
	Enzalutamide Plus Metformin Versus Enzalutamide Alone in Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 2 Trial (SAKK 08/14). Eur Urol Oncol Gillessen S, Gobat K, Cathomas R, Fischer N, Pereira Mestre R, Hermanns T, Rothschild SI, Mach N, Mingrone W, Ciriolo M, Müller B, Erdmann A, Schär C, Mamot C, Bohanes P, Omlin A, Bastian S, Ribi K, Mazzucchelli L, Barizzi J, Horvath LG, Scheinberg T, Mellor R, Schär S, Lin HM, Lim R, Pollak M, Turco F, Rothermundt C. PMID: 41862335 [PubMed - as supplied by publisher]
	MR ProGradeNet A Multi-Resolution Deep Learning Framework for Automated Prostate Cancer Grading from MRI. Semin Ultrasound CT MR Ghag KV, Jagdale J, Vyawahare M. PMID: 41862143 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 176973

Seite 1 von 8849

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung